Diversified Holdings · Industrial Conglomerates
Sunshine Holdings PLC is a diversified Sri Lankan conglomerate operating across healthcare, consumer goods and agribusiness, delivering products and services for consumers, institutions and industries in Sri Lanka and beyond.
SUN shares are down 9.1% over the past year and last closed at Rs 28.80 on Sep 30, 2026.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.2 | -2.3 | -12.2 | +8.8 | -3.4 | +0.3 | -4.5 | -1.0 | -1.7 | +0.0 | +0.0 | +0.0 |
| 2025 | -7.0 | -4.9 | -2.7 | +8.4 | +6.0 | +4.5 | +9.7 | +8.1 | +6.5 | +3.1 | +2.4 | +4.4 |
| 2024 | +0.4 | +6.4 | +10.1 | +3.3 | +0.0 | +3.2 | -5.5 | -1.7 | +3.9 | +8.6 | +10.3 | +35.1 |
| 2023 | +0.6 | +16.6 | +8.4 | -2.2 | -6.4 | +9.2 | +13.3 | +0.8 | +1.4 | -9.2 | +5.7 | +2.0 |
| 2022 | +36.3 | -18.7 | -26.8 | -9.5 | +6.3 | -18.3 | +35.9 | +7.4 | +11.1 | -22.3 | +2.7 | -5.6 |
| 2021 | +25.2 | -23.8 | +2.3 | -9.1 | +2.5 | +4.0 | +2.7 | -4.5 | -0.8 | +7.6 | +41.3 | +19.7 |
| 2020 | -3.5 | -2.8 | -13.3 | +0.0 | +0.0 | +6.8 | -8.5 | +11.6 | +19.2 | +1.7 | +27.1 | +10.1 |
| 2019 | +0.0 | +0.0 | -2.3 | +1.3 | -7.5 | -11.6 | +18.4 | -0.2 | +0.2 | +0.0 | +8.9 | -2.0 |
| 2018 | +7.6 | -6.3 | +4.3 | +3.6 | -4.2 | -0.9 | -3.4 | +0.7 | -5.5 | -1.0 | -10.1 | +8.0 |
| 2017 | -2.8 | -3.7 | -0.4 | +10.9 | +15.7 | +4.4 | +0.6 | -12.7 | +5.4 | +0.0 | -2.5 | -1.1 |
| 2016 | +5.5 | -10.2 | -0.4 | +0.4 | +3.6 | -3.8 | +1.0 | +9.9 | -3.6 | -4.5 | -4.9 | +1.6 |
| 2015 | +11.1 | -9.2 | -11.9 | +10.2 | -1.7 | -1.9 | +3.9 | +13.2 | -4.2 | -6.8 | +1.7 | -2.8 |
| 2014 | +14.3 | -6.2 | -4.3 | +8.7 | +9.0 | -2.9 | +20.6 | +5.0 | +14.8 | +0.2 | +11.0 | +1.1 |
| 2013 | -7.1 | +5.4 | -2.9 | +9.0 | +20.7 | +0.0 | -7.7 | -6.8 | +4.3 | -2.5 | -6.2 | -2.4 |
| 2012 | +0.0 | +0.0 | +0.0 | +10.0 | -9.1 | +25.0 | -4.0 | +16.7 | +10.7 | -12.3 | -4.4 | +7.7 |
| Average | +5.9 | -4.6 | -3.7 | +3.9 | +2.2 | +1.2 | +4.8 | +3.1 | +4.1 | -2.7 | +5.9 | +5.4 |
| ASPI average | +3.1 | -2.7 | -4.7 | +2.0 | +0.2 | +0.8 | +3.1 | +2.2 | +3.2 | -0.1 | +1.0 | +3.0 |
| Median | +0.6 | -4.9 | -2.5 | +6.0 | +1.2 | +0.3 | +1.0 | +0.8 | +3.9 | -0.5 | +2.6 | +1.8 |
| % up | 62% | 23% | 29% | 79% | 50% | 53% | 60% | 60% | 67% | 36% | 64% | 64% |
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | Rs 65.9B +11.2% | Rs 59.3B +6.8% | Rs 55.5B +7.0% | Rs 51.9B +61.3% | Rs 32.2B +32.2% | Rs 24.3B +16.8% | Rs 20.8B -8.0% | Rs 22.6B +6.6% |
| Operating profit | Rs 9.3B +0.1% | Rs 9.3B +7.1% | Rs 8.7B +23.7% | Rs 7.0B +22.7% | Rs 5.7B +61.9% | Rs 3.5B +21.2% | Rs 2.9B +31.1% | Rs 2.2B -14.0% |
| Net profit | Rs 5.0B -14.9% | Rs 5.9B -1.8% | Rs 6.0B +66.4% | Rs 3.6B -27.6% | Rs 5.0B +96.9% | Rs 2.5B +38.5% | Rs 1.8B +60.0% | Rs 1.1B -36.5% |
| EPS | 1.55 -27.9% | 2.15 -76.4% | 9.09 +94.7% | 4.67 -22.9% | 6.06 +78.8% | 3.39 -55.8% | 7.67 +73.1% | 4.43 -27.1% |
Compared with the same period a year earlier.
Per-share figures are as reported, not adjusted for splits.
| # | Company | Price | Mkt cap | P/E | P/B | EPS | ROE | Div Yield |
|---|---|---|---|---|---|---|---|---|
| 1 | BIL.N0000 | 4.90 | Rs 70.4B | - | 0.38 | -1.52 | -12.34% | 0.00% |
| 2 | SUN.N0000 · this company | 28.80 | Rs 56.7B | 21.0 | 2.92 | 1.37 | 13.96% | 6.25% |
| 3 | SPEN.N0000 | 137.50 | Rs 55.8B | 7.2 | 0.61 | 19.00 | 8.50% | 2.91% |
| 4 | RICH.N0000 | 25.30 | Rs 51.5B | 21.3 | 1.84 | 1.19 | 8.64% | 5.93% |
| 5 | GREG.N0000 | 35.60 | Rs 50.8B | 25.6 | 4.32 | 1.39 | 25.42% | 6.85% |
| 6 | CIC.N0000 | 27.80 | Rs 50.5B | 7.6 | 1.10 | 3.64 | 15.02% | 1.80% |
| 7 | BRWN.N0000 | 128.00 | Rs 27.2B | - | 0.24 | -73.95 | -13.85% | 0.00% |
| Peer median · 6 companies | - | - | 14.4 | 0.86 | - | - | 2.35% |
Sunshine Holdings PLC is a diversified Sri Lankan conglomerate operating across healthcare, consumer goods and agribusiness, delivering products and services for consumers, institutions and industries in Sri Lanka and beyond. The Group’s portfolio spans pharmaceuticals and medical devices, distribution and retail, local pharmaceutical manufacturing, branded consumer goods including tea and confectionery, and primary agri‑commodities such as palm oil and dairy. The Healthcare businesses encompass prescription and branded generics, medical devices, wholesale and retail distribution (including Healthguard distribution and retail operations) and local pharmaceutical manufacturing, supported by long‑term partnerships with multinational principals such as Zydus Lifesciences, Novo Nordisk, Cadila, Glenmark, Hilton Pharma and Galderma. The Consumer segment comprises branded consumer products, tea and confectionery and export‑oriented consumer initiatives, while the Agri business covers palm oil and dairy operations and is being repositioned toward higher‑value, export‑oriented opportunities (including the acquisition of Joint Agri Products Ceylon (Pvt) Ltd). Group level strategic investments and functions coordinate capital allocation, governance and cross‑business capabilities.
Sunshine is growing revenue, but the latest filed quarter shows its weakest June margins in seven years and falling profit. The shares also trade at a premium to diversified-holding peers.
Read the full report (Aug 12, 2026) →1 article in 30 days: 0 positive, 1 negative, 0 neutral.
Colombo Stock Exchange morning trade saw the ASPI fall 0.21% to 20,898.92 with market turnover at 143.28 million rupees; banks led turnover. Resus Energy said two subsidiaries' bids for 16 MW / 64 MWh battery energy storage systems integrated with solar plants were awarded, with equity needs of 650-800 million rupees.
SLEIS 2026 will examine Sri Lanka's Health Economy at a summit on 12-13 October 2026, with the session 'Reimagining Healthcare for a Modern Health Economy' featuring executives from Hemas and Sunshine and moderated by Sunshine's CEO; sponsors include Dialog and Hayleys. Registrations are open.
The Sri Lanka Economic & Investment Summit 2026 will feature a session 'Reimagining Healthcare for a Modern Health Economy' on Oct 12-13 to explore private-sector investment and opportunities across healthcare services, pharmaceuticals and medical technology. Panelists include Hemas Holdings (HHL.N0000) and Sunshine Holdings (SUN.N0000).
Fitch affirmed Ceat Kelani Holdings' National Long-Term Rating at 'AA+(lka)' with a Stable Outlook. Fitch highlighted CKH's market leadership and resilient finances but warned of near-term margin pressure from higher input and energy costs and import competition, with EBITDA net leverage seen peaking around 0.6x in FY28.
Colombo market slipped 0.61% to a six-week low as the ASPI closed at 21,133.41 amid rising oil prices and fears of an interest-rate hike; 172 counters fell, turnover was over Rs.1.6bn and foreign investors were net sellers of Rs.8m.
CFA Society Sri Lanka held the 13th Capital Market Awards on 10 September 2026, with Hemas Holdings Ltd. winning Gold for Best Investor Relations (Mid-to-Large Cap). hSenid Business Solutions won Small-Cap IR Gold; Sunshine Holdings (Silver) and John Keells Holdings (Bronze) were also recognised, and Softlogic received a sector-report award.
The Sri Lanka-Indonesia Business Council re-elected Sheamalee Wickramasingha as president for 2026/27 and said it will promote and facilitate inbound and outbound investment; a recent Sri Lanka-Indonesia business delegation sought commercial cooperation opportunities between firms from both countries.
The CFA Society Sri Lanka held its 13th Capital Market Awards on 10 Sept 2026; Hemas Holdings won Gold for Best Investor Relations (Mid-to-Large Cap) and hSenid Business Solutions won Gold for Best Investor Relations (Small Cap). Sunshine and John Keells took Silver and Bronze respectively; Hatton National Bank and Capital Alliance were event sponsors.
The Sri Lanka-Indonesia Business Council held its 3rd AGM and re-elected Sheamalee Wickramasingha as President. The council named an executive committee including representatives from hSenid, Amana Bank, Aitken Spence, Haycarb and Sunshine Holdings and said it will pursue closer trade and investment ties with Indonesia.
Colombo stock indices rose (ASPI +0.37% to 21,474.39; S&P SL20 +0.47% to 6,023.20) with several blue-chips higher. Kotagala Plantations resolved to amalgamate with its 99.999% subsidiary Rubber and Allied Products, offering 8.10 rupees cash to minority shareholders and cancelling the parent company's shares, subject to shareholder approval.